Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$21.17 n/a | n/a%
10/24/14 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -26.07M -22.24M -15.03M
Operating Gains/Losses 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 4.00M -4.02M 9.00M
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables 4.86M -3.18M 1.32M
(Decrease) Increase In Other Current Liabilities 18.71M 0.00 0.00
(Increase) Decrease In Other Working Capital 139.92M -5.48M -9.14M
Other Non-Cash Items 2.03M 824.00K 857.00K
Net Cash From Continuing Operations 144.54M -33.34M -11.29M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 144.54M -33.34M -11.29M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 75.30M 112.67M 113.53M
Purchases of Property, Plant & Equipment -557.00K -714.00K -2.25M
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments -132.54M -73.94M -103.88M
Other Cash from Investing Activities 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -57.79M 38.01M 7.41M
Issuance of Debt 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 250.00K 156.00K 22.00K
Repayment of Long-Term Debt 0.00 -346.00K -703.00K
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 105.67M 0.00 0.00
Net Cash From Financing Activities 105.92M -190.00K -681.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 192.67M 4.48M -4.56M

Portfolios with OMED

Latest OMED Headlines from TheStreet

More Financial News for OMED

Press Releases for OMED

See All Press Releases

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter